Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,464 recalls · Class II, newest first

Class II · Moderate risk

Cefepime

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Terminated Sterility / contamination Sentara Enterprises D-0629-2016
Class II · Moderate risk

Vancomycin HCL

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Terminated Sterility / contamination Sentara Enterprises D-0623-2016
Class II · Moderate risk

Dextrose-NaCl

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Terminated Sterility / contamination Sentara Enterprises D-0620-2016
Class II · Moderate risk

Intralipid

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Terminated Sterility / contamination Sentara Enterprises D-0618-2016
Class II · Moderate risk

Solumedrol

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Terminated Sterility / contamination Sentara Enterprises D-0617-2016
Class II · Moderate risk

Cefazolin

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Terminated Sterility / contamination Sentara Enterprises D-0615-2016
Class II · Moderate risk

Sod Chloride

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

Terminated Sterility / contamination Sentara Enterprises D-0613-2016
Class II · Moderate risk

WellPatch¿ Capsaicin Pain Relief Patch

Labeling: Incorrect Instructions; The word not is missing from the following sentences "do bandage tightly or cover with any type of wrap except clothing and "do use with a heating pad or with other heat sources in the Drug Facts panel "Warning" section

Terminated Labeling / mix-up The Mentholatum Co. NDC 10742-8126-2 D-0018-2016
Class II · Moderate risk

Zinc Sulfate

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3226-07 D-0294-2016
Class II · Moderate risk

Voriconazole Solution

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-2815-10 D-0293-2016

Recalls by year